These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 8800208)

  • 1. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
    Agostini I; Navarro JM; Rey F; Bouhamdan M; Spire B; Vigne R; Sire J
    J Mol Biol; 1996 Sep; 261(5):599-606. PubMed ID: 8800208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-MYB transactivates its own promoter through SP1-binding sites.
    Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
    Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation.
    Roberts SG; Ha I; Maldonado E; Reinberg D; Green MR
    Nature; 1993 Jun; 363(6431):741-4. PubMed ID: 8515819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recruitment of TBP or TFIIB to a promoter proximal position leads to stimulation of RNA polymerase II transcription without activator proteins both in vivo and in vitro.
    Huh JR; Park JM; Kim M; Carlson BA; Hatfield DL; Lee BJ
    Biochem Biophys Res Commun; 1999 Mar; 256(1):45-51. PubMed ID: 10066420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo.
    Veschambre P; Simard P; Jalinot P
    J Mol Biol; 1995 Jul; 250(2):169-80. PubMed ID: 7608968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.
    Kashanchi F; Thompson J; Sadaie MR; Doniger J; Duvall J; Brady JN; Rosenthal LJ
    Virology; 1994 May; 201(1):95-106. PubMed ID: 8178493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
    Ghosh S; Selby MJ; Peterlin BM
    J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.
    Popova B; Bilan P; Xiao P; Faught M; Capone JP
    Virology; 1995 May; 209(1):19-28. PubMed ID: 7747469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
    Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
    Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved.
    Forget J; Yao XJ; Mercier J; Cohen EA
    J Mol Biol; 1998 Dec; 284(4):915-23. PubMed ID: 9837715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activator-induced conformational change in general transcription factor TFIIB.
    Roberts SG; Green MR
    Nature; 1994 Oct; 371(6499):717-20. PubMed ID: 7935820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The strength of acidic activation domains correlates with their affinity for both transcriptional and non-transcriptional proteins.
    Melcher K
    J Mol Biol; 2000 Sep; 301(5):1097-112. PubMed ID: 10966808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-one base pair repeat elements influence the ability of a Gal4-Tax fusion protein to transactivate the HTLV-I long terminal repeat.
    Connor LM; Oxman MN; Brady JN; Marriott SJ
    Virology; 1993 Aug; 195(2):569-77. PubMed ID: 8337832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
    Bartusel T; Schubert S; Klempnauer KH
    Gene; 2005 May; 351():171-80. PubMed ID: 15922873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activity of the activation function 2 of the human hepatocyte nuclear factor 4 (HNF-4alpha) is differently modulated by F domains from various origins.
    Suaud L; Formstecher P; Laine B
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):161-9. PubMed ID: 10229671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between transcription factors Sp1 and YY1.
    Seto E; Lewis B; Shenk T
    Nature; 1993 Sep; 365(6445):462-4. PubMed ID: 8003102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of an N-terminal transcriptional activation domain within Brn3b/POU4f2.
    Martin SE; Mu X; Klein WH
    Differentiation; 2005 Feb; 73(1):18-27. PubMed ID: 15733064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.